|
|---|
|
|
|
|
|
m*********n
发帖数: 6098 | 1 【 以下文字转载自 Stock 讨论区 】
发信人: JustinCase (JustinCase), 信区: Stock
标 题: 有人关注CPIX吗？
发信站: BBS 未名空间站 (Sun Aug 22 13:34:49 2010, 美东)
FDA review刚推迟了，要是跌个10％，是不是可以捞点阿？ | K********g
发帖数: 9389 | 2 如果想买的话，我觉得一定要弄清楚为何5月份暴跌？这是关键
【在 m*********n 的大作中提到】
: 【 以下文字转载自 Stock 讨论区 】
: 发信人: JustinCase (JustinCase), 信区: Stock
: 标 题: 有人关注CPIX吗？
: 发信站: BBS 未名空间站 (Sun Aug 22 13:34:49 2010, 美东)
: FDA review刚推迟了，要是跌个10％，是不是可以捞点阿？
| g******0
发帖数: 1165 | 3 CPIX看了眼 6月 8月有2跟好粗好长的绿柱 可价格就是上不去 why? | g******0
发帖数: 1165 | | K********g
发帖数: 9389 | 5 呵呵呵，赞一个。
如果到了5以下，我就会捞一点。
【在 g******0 的大作中提到】
: 又看了一样 it是去年8月份的IPO？
| g******0
发帖数: 1165 | 6 有啥关键的 5月份中旬的暴跌就是因为ER呗
恩
看完这份10-Q就啥都懂了
http://biz.yahoo.com/e/100517/cpix10-q.html
【在 K********g 的大作中提到】
: 如果想买的话，我觉得一定要弄清楚为何5月份暴跌？这是关键
| g******0
发帖数: 1165 | 7 周五晚上出来的被延期的消息 当晚盘后跌了8.08%
量是月均量的2/3
俺随便看了眼 这次被延期的药今天4月份在加拿大上市了？？CPIX公司出配方 另外一
家加拿大本土公司代工并销售？
俺看的是5月份的10-Q
Supplemental New Drug Application
In March 2010, we submitted a supplemental new drug application (sNDA) to
the U.S. Food and Drug Administration (FDA) for the use of Acetadote in
patients with non-acetaminophen acute liver failure. The sNDA includes data
from a clinical trial led by investigators at the University of Texas
Southwestern Medical Center indicating that acute liver failure patients
treated with Acetadote have a significantly improved chance of survival
without a transplant. These patients can also survive a significant number
of days longer without transplant, providing patients requiring transplant
increased time for a donor organ to become available.
Acute liver failure is associated with a high mortality rate and frequent
need for liver transplantation. Approximately half of acute liver failure
cases are caused by acetaminophen poisoning while the other half result from
a variety of causes including hepatitis and alcohol. Currently,
transplantation of the liver is the only treatment for patients with liver
failure not caused by acetaminophen overdose.
In May 2010, the FDA officially accepted the sNDA and granted a priority
review. In addition to expanded labeling for Acetadote, we have requested
additional exclusivity for the product. If approved, we expect to begin
marketing Acetadote with the new indication in 2011.
Australian Regulatory Approval
In April 2010, the Therapeutic Goods Administration approved Acetadote for
marketing in Australia. We previously granted an exclusive license to Phebra
Pty Ltd., an Australian-based specialty pharmaceutical company, to
commercialize Acetadote in Australia. Phebra is now preparing for the
Australian launch of the product, which it expects to commence this year.
Under our agreement, Phebra is responsible for ongoing regulatory
requirements, marketing, distribution and sales of Acetadote in Australia
while we maintain responsibility for product formulation, development and
manufacturing. In exchange for the product license, Cumberland receives
upfront and milestone payments, a transfer price and royalties on future
sales. Caldolor�
License Agreement for Canada
In April 2010, we entered into an exclusive agreement with Alveda
Pharmaceuticals Inc., a Toronto-based specialty pharmaceutical company, for
the commercialization of Caldolor in Canada. Under the agreement, Alveda
will seek Canadian regulatory approval for Caldolor and, upon approval, will
handle ongoing regulatory requirements as well as product marketing,
distribution and sales throughout Canada. Cumberland will maintain
responsibility for product formulation, development and manufacturing. In
exchange for the license to the product, Cumberland will receive royalties
on future sales of Caldolor in addition to upfront and milestone payments as
well as a transfer price.
【在 K********g 的大作中提到】
: 呵呵呵，赞一个。
: 如果到了5以下，我就会捞一点。
| g******0
发帖数: 1165 | 8 从公司首页看来的公司产品
For information on our marketed products, please visit the product websites
by clicking on the links below.
Acetadote®
This product prevents or reduces liver damage resulting from acetaminophen
overdose, the leading cause of drug toxicity in the U.S. Promoted to
hospitals and poison control centers nationwide, Acetadote is the first
injectable treatment available in the country for this potentially lethal
overdosing occurrence.
Kristalose®
Kristalose is a prescription laxative that we believe has significant
advantages over competitive products, and is being promoted to the most
prolific prescribers of the class - gastroenterologists.
Caldolor®
Caldolor is our intravenous formulation of ibuprofen which was approved by
the FDA in June 2009. Caldolor is the first injectable product available in
the United States for the treatment of pain and fever.
这次被延期的是Acetadote@
俺不懂药 达人们来说说哟 别老藏着掖着了 就更老偷偷摸摸打飞机一样 伤神的哟 | m*********n
发帖数: 6098 | | K********g
发帖数: 9389 | 10 还是很有希望的，呵呵呵
【在 m*********n 的大作中提到】
: 下5的希望好象不大呀
: 開文他爹看看?
| m*********n
发帖数: 6098 | |
|
|
|
|
|
|
